Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q4 EPS of ($0.64), $0.07 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $22.6 million, versus $21 million estimate.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.